28 July 2017 ORYZON Reports Financial Results and Corporate Update for the 1st Half Ended June 30, 2017
24 July 2017 ORYZON presents final data on the Phase I trial with ORY-2001 at the Alzheimer’s Association International Conference (AAIC-2017)
31 May 2017 Oryzon Genomics to Participate in a Panel at the JMP Securities Life Sciences Conference and Present at the Jefferies 2017 Global Health Conference
16 May 2017 Oryzon announces appointment of new Chief Medical Officer and expansion of its Medical Department
24 April 2017 ORYZON Announces New Grant from Alzheimer’s Drug Discovery Foundation (ADDF) to develop a companion marker for its ORY-2001 epigenetic drug
3 April 2017 ORYZON presents data on the Phase I trial with ORY-2001 at the 13th International Conference on Alzheimer’s and Parkinson’s diseases